Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disease-drug database for pharmacogenomic-based prescribing.

Clinical pharmacology and therapeutics - 1 Aug 2016

Hussain S, Kenigsberg B B, Danahey K, Lee Y M, Galecki P M, Ratain M J, O'Donnell P H

Abstract excerpt

Providers have expressed a strong desire to have additional clinical decision-support tools to help with interpretation of pharmacogenomic results. We developed and tested a novel disease-drug association tool that enables pharmacogenomic-based prescribing to treat common diseases. First, 324 drugs were mapped to 484 distinct diseases (mean number of drugs treating each disease was 4.9; range 1-37). Then the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Factual
Share to Decision Support Systems, Clinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pharmacogenetics

Share to Practice Patterns, Physicians'

Share to Precision Medicine

Share to Tertiary Care Centers

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 26940584
DOI: 10.1002/cpt.364
PMCID: PMC5570547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disease-drug database for pharmacogenomic-based prescribing.PMID 26940584Read ↗

Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Semantic proximity Read ↗

Genotype-predicted drug response phenotypes and their co-occurrence with dispensed medicines among 738,531 participants in the UK Our Future Health studySemantic proximity Read ↗

Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.Semantic proximity Read ↗

Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.Semantic proximity Read ↗

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG).Semantic proximity Read ↗

Pharmacogenetics: Opportunities for the All of Us Research Program and Other Large Data Sets to Advance the FieldSemantic proximity Read ↗

The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.Semantic proximity Read ↗

Clinical PharmacogenomicsSemantic proximity Read ↗

CLINICAL IMPLEMENTATION OF PREEMPTIVE PHARMACOGENOMICS TESTING FOR PERSONALIZED MEDICINE AT AN ACADEMIC MEDICAL CENTERSemantic proximity Read ↗

Pharmacogenomics. Examining genes to personalize drugs.Semantic proximity Read ↗

A SNPshot of PubMed to associate genetic variants with drugs, diseases, and adverse reactions.Semantic proximity Read ↗

PharmGKB: an integrated resource of pharmacogenomic data and knowledge.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.